Recurrent Clostridium Difficile Infection Clinical Trial
The Fecal Microbiota Transplantation (FMT) product PRIM-DJ2727 is prepared from human stool from a healthy, screened donor. Requestors will contact the study team about the product (PRIM-DJ2727) by email, visit, or phone call. A screening list for donors will be provided to make sure that the list fits the requestor's requirements. A basic fee will be requested to recover the cost of making the product. After an agreement is made, a contract will be signed between the 2 parties. A week before the treatment, requestors will contact the study team for possible FMT product delivery. Delivery method will be confirmed for delivery by personnel (within 10 minutes driving distance) or by using FedEx services. Each delivered product will have an approved delivery form signed and dated by both the person who prepared the delivery and the person who received the package.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05201079 -
Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin
|
Phase 3 | |
Terminated |
NCT01226992 -
Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04960306 -
Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection
|
Phase 3 | |
Completed |
NCT03462459 -
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
|
Phase 2 | |
Recruiting |
NCT06237452 -
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
|
Phase 3 | |
Recruiting |
NCT05826418 -
Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation
|
N/A | |
Completed |
NCT03497806 -
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiotaâ„¢ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
|
Phase 2 | |
Suspended |
NCT01202630 -
BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection
|
Phase 3 | |
Terminated |
NCT03973697 -
Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection
|
Phase 2 | |
Completed |
NCT03353506 -
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
|
Phase 2 | |
Completed |
NCT01925417 -
Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea
|
Phase 2 |